Description
Monuvir 200Mg - Anti-COVID Generic Drug Molnupiravir
Packaging Size | 10 Capsule |
Composition | Molnupiravir |
Treatment | Covid 19 |
Strength | 200 Mg |
Prescription/Non prescription | Prescription |
Brand | Monuvir |
Form | Capsule |
Shelf life | 2 Years |
Country of Origin | Made in Bangladesh |
Additional Information
Molnupiravir is the world’s first oral pill to treat symptomatic COVID-19 which was approved by the UK’s Medicines and Healthcare products Regulatory Agency on 4 November 2021. Molnupiravir is originally developed by the US based pharma major Merck, Sharp & Dohme (MSD) and Ridgeback Biotherapeutics.